Ziv-aflibercept | Interleukin Related interleukin-related.com

Product Name :
Ziv-aflibercept

Search keywords :
PLGF

drugId :
null

Target Vo:
Placental Growth Factor

Target Vo Short Name :
PGF

Moa_Name:
Placental Growth Factor inhibitors

First Approval Country :
United States

First Approval Date Filter:
2012

Origin Company_Name :
Regeneron Pharmaceuticals Inc

Active Company_Name :
Dana-Farber Cancer Institute

Active Indication_Name:
Colorectal Neoplasms

In Active Indication_Name:
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Termination Status :

China Termination Status :
Phase 3 Clinical

Highest Status:
Approved

China Highest Status:
Pending

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Durvalumab (anti-PD-L1) medchemexpress
Birtamimab Cancer
CYP11A1 Antibody: CYP11A1 Antibody is an unconjugated, approximately 53/57 kDa, rabbit-derived, anti-CYP11A1 polyclonal antibody. CYP11A1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit, sheep background without labeling.

Author: Interleukin Related

Related Posts